Elucidation of the pathogenesis and new diagnostic or therapeutic methods for biliary tract diseases through bile juice analysis.

Elucidation of the pathogenesis and new diagnostic or therapeutic methods for biliary tract diseases through bile juice analysis. - Elucidation of the pathogenesis and new diagnostic or therapeutic methods for biliary tract diseases through bile juice analysis.

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000052589

Enrollment

350

Registered

2024-01-01

Start date

2024-01-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bile duct cancer, primary sclerosing cholangitis, IgG4-related sclerosing cholangitis, secondary sclerosing cholangitis, bile duct stones, cholangitis

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Adults 18 years and older who undergo endoscopic retrograde cholangiopancreatography (ERCP) for biliary tract disease at Nagoya University Hospital.

Exclusion criteria

Exclusion criteria: Patients considered ineligible for participation in this study by the principal investigator or research assistant. Cases in which ERCP is difficult to perform or ENBD tube placement is difficult Patients who have undergone biliary tract surgery

Design outcomes

Primary

Measure	Time frame
Analysis of DNA, RNA, and exosomes in bile to identify markers that reflect the diagnosis of benign or malignant biliary disease and its prognosis.	—

Countries

Japan

Contacts

Public ContactYoshihisa Takada

Nagoya University Graduate School of Medicine Department of Gastroenterology and Hepatology

ytakada@med.nagoya-u.ac.jp0527412111

Outcome results